Supporting Your Investment in China with Expertise and Flexibility
Changing regulations have cemented China's status as the second-largest pharmaceutical market and led to increased investment from multinational sponsors throughout all phases of development.
为全球构建你的竞争优势clinical trials with the integrated and collaborative team in China.